Malignant atrophic papulosis: which is the primary driver - interferon or complement overactivation?

Affiliations

Editorial

Marie Robert et al. Br J Dermatol. 2025.

. 2025 Jun 20;193(1):10.

doi: 10.1093/bjd/ljaf148.

¹ Department of Internal Medicine, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France.

No abstract available

Conflict of interest statement

Conflicts of interest: The authors declare they have no conflicts of interest.

Rescue therapy in malignant atrophic papulosis: a new era of promising treatments targeting interferon and complement pathways.
El Maamar Y, Pruvot C, Farhat MM, Noiret B, Laroye C, Barbe A, Ghannem L, Labalette P, Staumont-Salle D, Launay D, Hachulla É, Ledoult E. El Maamar Y, et al. Br J Dermatol. 2025 Jun 20;193(1):180-182. doi: 10.1093/bjd/ljaf106. Br J Dermatol. 2025. PMID: 40127150 No abstract available.